AVDL

AVDL

USD

Avadel Pharmaceuticals plc Ordinary Share

$18.780+0.030 (0.160%)

Echtzeitkurs

Healthcare
Drug Manufacturers - Specialty & Generic
Irland

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$18.750

Hoch

$18.780

Tief

$18.680

Volumen

1.08M

Unternehmensfundamentaldaten

Marktkapitalisierung

1.8B

Branche

Drug Manufacturers - Specialty & Generic

Land

Ireland

Handelsstatistiken

Durchschnittliches Volumen

2.43M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $6.38Aktuell $18.780Hoch $19.06

Ähnliche Nachrichten

Analyst Upgrades

UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20

UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals from Buy to Neutral and maintains the price target from $20 to $20.

Mehr anzeigen
UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20
Analyst Upgrades

Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals from Outperform to Market Perform and announces $18.5 price target.

Mehr anzeigen
Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

Mehr anzeigen
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
PR Newswire

HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Mehr anzeigen
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
Analyst Upgrades

Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals from Buy to Hold and lowers the price target from $22 to $20.

Mehr anzeigen
Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20
Analyst Upgrades

Needham Downgrades Avadel Pharmaceuticals to Hold

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals from Buy to Hold.

GlobeNewswire

Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement

DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.